Latest From Biotech Now

California Continues Responsible Support for Interchangeability of Biologic Drugs

State Capitol

Yesterday, California’s State Assembly Committee on Appropriations took another decisive step when they unanimously voted in support of the revised SB 598 by recommending it back to the full Assembly after minor modifications. This is another important step taken by the California State Legislature to ensure patients and physicians who are managing chronic conditions are made fully aware of which biologic drug is ultimately administered by the pharmacist. When battling a serious disease, patients, physicians Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

Involving Patients in the Research Process

PsAM-2013-Facebook-Shareable115x76

According to the National Psoriasis Foundation, as many as 7.5 million Americans live with psoriasis, making it the most common autoimmune disease in the country. More than just a skin condition, psoriasis puts people at increased risk for other serious diseases such as heart disease, diabetes and depression. Up to 30 percent of people with psoriasis develop psoriatic arthritis, an inflammatory joint disease. A complex disease with a genetic component, psoriasis is not contagious. While Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO Investor Forum Company Snapshot: NovelMed Therapeutics

NovelMed

NovelMed Therapeutics will be presenting at the upcoming BIO Investor Forum in October in San Francisco. Read below to learn more about their antibodies portfolio, what differentiates their company for the competition, and other interesting facts about the company. Company Snapshot What is your company’s lead product or technology? NovelMed has developed a portfolio of fully humanized monoclonal antibodies that selectively target only the disease-associated Complement System. As such, NovelMed’s antibodies are active against multiple Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

GAINing Ground in Antibiotics

GAIN

With the rise of antibiotic resistant “superbugs” in recent years, everyone agrees there is an urgent need to develop new and effective antibiotics. One measure designed to spur such development is the Generating Antibiotics Incentives Now (GAIN) Act, which was enacted last year. The law provides an additional five years of market exclusivity and priority FDA review for innovative antibiotics that target qualifying pathogens. Much of the current research in the field is being done Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , ,

When Crop Vandalism Kills Children…

Golden Rice

In the days following the senseless destruction of Golden Rice field trials in the Philippines that occurred earlier this month, there has been much response on social media and in the blogosphere. “Our Golden Rice research is part of our humanitarian work to reduce vitamin A deficiency that mostly affects women and children – causing sickness, blindness, and even death,” said Dr. Bruce Tolentino, deputy director general of communications and partnerships at the International Rice Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,